DAVENPORT & Co LLC

Position in JNJ — Johnson & Johnson

CIK 887777 RICHMOND, VA

Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$219,022,204

+$936,014 QoQ

Shares Held

862,394

-3.3% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

1.35%

of 13F equity value

Holder Rank

#191

of 4,664 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Jun 30, 2026

CallValue

$1,879,378

CallShares

7,400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DAVENPORT & Co LLC holds $494,810,441 across 13 Drug Manufacturers - General names. JNJ ranks #1 (44.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	862,394	$219,022,204
2	SNY	Sanofi	2,001,451	$85,381,899
3	LLY	ELI LILLY & Co	40,627	$48,729,246
4	ABBV	AbbVie Inc.	191,426	$48,170,438
5	MRK	Merck & Co., Inc.	271,897	$34,938,764
6	AMGN	Amgen Inc	57,790	$20,926,914
7	PFE	Pfizer Inc	446,366	$10,748,493
8	BMY	Bristol Myers Squibb Co	120,870	$6,964,529

All Filings in JNJ

Export CSV

39 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,879,378	7,400	-41.7%	Call	Sole	2026-07-13
2026-06-30	$219,022,204	862,394	-3.3%	Shares	Sole	2026-07-13
2026-03-31	$3,104,388	12,700	-6.6%	Call	Sole	2026-04-15
2026-03-31	$218,086,190	892,187	-19.2%	Shares	Sole	2026-04-15
2025-12-31	$228,650,156	1,104,857	-1.6%	Shares	Sole	2026-01-12
2025-12-31	$2,814,520	13,600	-0.7%	Call	Sole	2026-01-12
2025-09-30	$208,091,303	1,122,270	-1.7%	Shares	Sole	2025-10-15
2025-09-30	$2,540,254	13,700	+0.7%	Call	Sole	2025-10-15
2025-06-30	$2,077,400	13,600	+0.7%	Call	Sole	2025-07-22
2025-06-30	$174,460,815	1,142,133	-7.7%	Shares	Sole	2025-07-22
2025-03-31	$2,238,840	13,500	+22.7%	Call	Sole	2025-04-28
2025-03-31	$205,282,058	1,237,832	-1.9%	Shares	Sole	2025-04-28
2024-12-31	$1,590,820	11,000	+1.9%	Call	Sole	2025-01-24
2024-12-31	$182,532,422	1,262,152	-6.6%	Shares	Sole	2025-01-24
2024-09-30	$1,750,248	10,800	+17.4%	Call	Sole	2024-10-24
2024-09-30	$219,068,008	1,351,771	+0.5%	Shares	Sole	2024-10-24
2024-06-30	$196,612,531	1,345,187	+14.2%	Shares	Sole	2024-08-06
2024-06-30	$1,344,672	9,200	+12.2%	Call	Sole	2024-08-06
2024-03-31	$186,378,034	1,178,191	-14.1%	Shares	Sole	2024-05-03
2024-03-31	$1,297,158	8,200	+90.7%	Call	Sole	2024-05-03
2023-12-31	$673,982	4,300	+19.4%	Call	Sole	2024-01-23
2023-12-31	$214,992,107	1,371,648	+13.2%	Shares	Sole	2024-01-23
2023-09-30	$560,700	3,600	+100.0%	Call	Sole	2023-10-17
2023-09-30	$188,767,442	1,211,990	-25.4%	Shares	Sole	2023-10-17
2023-06-30	$297,936	1,800	—	Call	Sole	2023-07-20
2023-06-30	$268,753,665	1,623,693	-10.6%	Shares	Sole	2023-07-20
2023-03-31	$281,557,500	1,816,500	-0.9%	Shares	Sole	2023-04-27
2022-12-31	$323,867,990	1,833,388	-0.1%	Shares	Sole	2023-01-20
2022-09-30	$299,688,657	1,834,529	-0.3%	Shares	Sole	2022-10-11
2022-06-30	$326,608,636	1,839,945	+12.9%	Shares	Sole	2022-07-18
2022-03-31	$288,848,390	1,629,794	-0.2%	Shares	Sole	2022-05-02
2021-12-31	$279,275,880	1,632,524	+9.4%	Shares	Sole	2022-02-10
2021-09-30	$241,045,694	1,492,543	+6.6%	Shares	Sole	2021-10-14
2021-06-30	$230,620,843	1,399,908	+8.2%	Shares	Sole	2021-07-28
2021-03-31	$212,699,633	1,294,187	-0.6%	Shares	Sole	2021-04-28
2020-12-31	$204,818,266	1,301,425	+0.4%	Shares	Sole	2021-01-13
2020-09-30	$192,966,792	1,296,123	-1.5%	Shares	Sole	2020-10-15
2020-06-30	$184,967,404	1,315,277	-11.2%	Shares	Sole	2020-07-28
2020-03-31	$194,118,951	1,480,355	—	Shares	Sole	2020-05-05
No filing history on record for this holder in this stock.